Incorporated in August 2004, Ahmedabad-based Corona Remedies is a pharmaceutical company developing, manufacturing, and marketing products.
Incorporated in August 2004, Ahmedabad-based Corona Remedies is a pharmaceutical company developing, manufacturing, and marketing products.Corona Remedies is scheduled to finalize the basis of allotment of its shares on Thursday, December 11. Bidders will get the messages, alerts or emails for debit of their funds or revocations of their IPO mandate by Friday, December 12 or latest by weekend. The pharma player saw a muted response from the investors.
The issue was subscribed a whopping 137.04 times, attracting bids worth over Rs 66,500 crore via over 41.87 lakh applications. The portion for qualified institutional bidders (QIBs) was booked 278.52 times, while the quota for non-institutional investors (NIIs) was subscribed 208.88 times. The allocations for retail investors and employees were subscribed 28.73 times and 14.72 times, respectively.
Here is the tentative odds allotment matrix in Cororna Remedies IPO for the investors:
Incorporated in August 2004, Ahmedabad-based Corona Remedies is a pharmaceutical company developing, manufacturing, and marketing products in women’s healthcare, cardiology, pain management, urology, and other therapeutic areas. It has a diverse portfolio of 71 brands with 2,671 medical representatives in 22 states.
The grey market premium of Corona Remedies has seen some rebound thanks to solid bidding and decent listings lately amid muted market sentiments in the listed markets. Last heard, the company was commanding a grey market premium (GMP) of Rs 295-300 apiece, suggesting a listing pop of 28 for the investors. The GMP stood around Rs 250-260 during the bidding process.
JM Financial, IIFL Capital Service and Kotak Mahindra Capital Company are the book running lead managers of Corona Remedies IPO and Bigshare Service is the registrar of the issue. Credit of shares and/or initiation of refund shall be done on Friday, December 12. Shares of the company shall be listed on both BSE and NSE with December 15 as the date of listing.
Investors, who had bid for the issue of Corona Remedies IPO, can check the allotment status on the Bombay Stock Exchange (BSE) website:
Investors can also check the allotment status on the online portal of Bigshare Services Limited (https://ipo.bigshareonline.com/IPO_Status.html), the registrar to the issue.
The registrar is a Sebi-registered entity, qualified to act as such and which electronically processes all applications and carries out the allotment process, as per the prospectus. The registrar is responsible for complying with the timelines for updating the electronic credit of shares to successful applicants, dispatching and uploading refunds, and attending to all investor-related queries.